The authors have no conflicts of interest to report.
BRIEF REPORT: Methadone Treatment of Injecting Opioid Users for Prevention of HIV Infection
Article first published online: 7 DEC 2005
Journal of General Internal Medicine
Volume 21, Issue 2, pages 193–195, February 2006
How to Cite
Gowing, L. R., Farrell, M., Bornemann, R., Sullivan, L. E. and Ali, R. L. (2006), BRIEF REPORT: Methadone Treatment of Injecting Opioid Users for Prevention of HIV Infection. Journal of General Internal Medicine, 21: 193–195. doi: 10.1111/j.1525-1497.2005.00287.x
- Issue published online: 8 MAR 2006
- Article first published online: 7 DEC 2005
- Manuscript received February 16, 2005 Initial editorial decision April 12, 2005 Final acceptance September 2, 2005
- HIV infections: prevention and control;
- substance abuse;
- intravenous: drug therapy;
- opioid-related disorders: drug therapy;
- methadone: therapeutic use
OBJECTIVE: To assess the effects of oral substitution treatment for opioid-dependent injecting drug users on HIV risk behaviors and infections.
DATA SOURCES: Multiple electronic databases were searched. Reference lists of retrieved articles were checked.
METHODS: Because of varying methodologies of available studies, this systematic review was limited to a descriptive summary, looking at consistency of outcomes across studies.
RESULTS: Twenty-eight studies involving methadone treatment were included in the review. Methadone maintenance treatment is associated with statistically significant reductions in injecting use and sharing of injecting equipment. It is also associated with reductions in numbers of injecting drug users reporting multiple sex partners or exchanges of sex for drugs or money, but has little effect on condom use. It appears that the reductions in risk behaviors do translate into fewer cases of HIV infection.
CONCLUSIONS: Methadone maintenance treatment for injecting drug users significantly reduces the risk of transmission of HIV and should be provided as a component of a strategic approach to the prevention and control of HIV infection. There is insufficient evidence to determine whether other forms of oral substitution treatment also reduce the risk of HIV transmission.